Sharing Alzheimer’s research data with the world
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study.
The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
For Researchers
About Data+Samples
Learn About ADNI data and samples
Access Data
Access data through IDA
Impact of ADNI
This tool provides interactive views of aggregate-level clinical data contributed longitudinally by over 2,500 participants around the U.S. and Canada.
